# UNIVERSITY OF GEORGIA: Extracellular Vesicle-Enhanced Mitochondrial Therapy for ALS and Neurodegeneration

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF GEORGIA |
| Location | ATHENS, GA |
| Project | Extracellular Vesicle-Enhanced Mitochondrial Therapy for ALS and Neurodegeneration |
| Project number | 1R21NS148841-01A1 |
| Mechanism | R21 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $402,347 |
| Awarded | 2026-09-02 |
| Project period | 2026-09-02 to 2028-08-31 |
| UEI | NMJHD63STRC5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11514491). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.